Weekly Investment Analysts’ Ratings Changes for Claritev (CTEV)

Claritev (NYSE: CTEV) recently received a number of ratings updates from brokerages and research firms:

• 8/12/2026 – Claritev had its “overweight” rating reaffirmed by Piper Sandler. They now have a $73.00 price target on the stock.
• 8/12/2026 – Claritev had its price target raised by Wells Fargo & Company from $22.00 to $30.00. They now have an “equal weight” rating on the stock.
• 8/10/2026 – Claritev had its “buy” rating reaffirmed by Citigroup Inc.. They now have a $45.00 price target on the stock, up from $40.00.
• 8/10/2026 – Claritev had its price target raised by Canaccord Genuity Group Inc. from $37.00 to $43.00. They now have a “buy” rating on the stock.
• 8/8/2026 – Claritev was upgraded by Wall Street Zen from “sell” to “hold”.
• 7/21/2026 – Claritev had its price target raised by Canaccord Genuity Group Inc. from $32.00 to $37.00. They now have a “buy” rating on the stock.
• 7/17/2026 – Claritev was downgraded by Zacks Research from “hold” to “strong sell”.
• 6/24/2026 – Claritev had its “sell (d-)” rating reaffirmed by Weiss Ratings.

Insider Transactions at Claritev

In related news, SVP William B. Mintz sold 8,431 shares of Claritev stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $34.24, for a total value of $288,677.44. Following the sale, the senior vice president directly owned 71,195 shares in the company, valued at $2,437,716.80. This trade represents a 10.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 7.40% of the company’s stock.

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.